poisar

Stocks · News reference

Nir Sassi Departs Indaptus Therapeutics to Join Nasus Pharma as CFO

Fiscal.ai

Nir Sassi, the former Chief Financial Officer of Indaptus Therapeutics, has been appointed as the new CFO of Nasus Pharma, effective November 11, 2026.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading